Revance Therapeutics, Inc. (RVNC)
| Market Cap | 870.87M |
| Revenue (ttm) | 62.98M |
| Net Income (ttm) | -296.52M |
| Shares Out | 71.79M |
| EPS (ttm) | -4.47 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 563,434 |
| Open | 12.34 |
| Previous Close | 12.36 |
| Day's Range | 11.84 - 12.48 |
| 52-Week Range | 11.84 - 33.83 |
| Beta | 0.87 |
| Analysts | Buy |
| Price Target | 28.11 (+131.7%) |
| Earnings Date | Feb 21, 2022 |
About RVNC
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection (DAXI), which has completed phase III clinical trials for the treatment of glabellar (frown) lines and cervical dystonia; is in phase II clinical trials to treat upper facial lines, moderate or severe dynamic forehead lines, and moderate or severe late...
Financial Performance
Financial StatementsAnalyst Forecast
According to 10 analysts, the average rating for RVNC stock is "Buy." The 12-month stock price forecast is 28.11, which is an increase of 131.74% from the latest price.
News
RVNC SHAREHOLDER ALERT: Jakubowitz Law Reminds Revance Shareholders of a Lead Plaintiff Deadline of February 8, 2022
NEW YORK, Jan. 28, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Revance Therapeutics, Inc. (NASDAQ: RVNC). To rec...
Investor Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud C...
Radnor, Pennsylvania--(Newsfile Corp. - January 28, 2022) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed agai...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Revance Therapeutics, I...
NEW YORK, Jan. 27, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Revance Therapeutics, Inc. ("Revance" or the "Company") (NASDAQ: RVNC) and certain of i...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Revance Therapeutics, Inc. of a Class Action Lawsui...
NEW YORK, Jan. 27, 2022 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Revance Therapeuti...
RVNC Investors Have Opportunity to Lead Revance Therapeutics, Inc. Securities Fraud Lawsuit
LOS ANGELES, Jan. 27, 2022 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against...
Revance Therapeutics Shareholder Alert
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Revance Therapeutics To Contact Him Directly To Discuss Their OptionsNew York, New York--...
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Revance Therapeutics, Inc. of a Class Action Lawsuit a...
NEW YORK, Jan. 26, 2022 /PRNewswire/ -- The Gross Law Firm, securities class action litigators, issues the following notice to shareholders of Revance Therapeutics, Inc.: Shareholders who purchased shar...
Shareholder Action Alert: The Schall Law Firm Encourages Investors in Revance Therapeutics, Inc. with Losses of $100,...
Los Angeles, California--(Newsfile Corp. - January 26, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Revance Therapeutic...
ROSEN, A LEADING LAW FIRM, Encourages Revance Therapeutics, Inc. Investors with Losses Exceeding $100K to Secure Coun...
NEW YORK, Jan. 25, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Revance Therapeutics, Inc. (NASDAQ: RVNC) between November 25, 201...
Investor Action Reminder: The Schall Law Firm Encourages Investors in Revance Therapeutics, Inc. with Losses of $100,...
Los Angeles, California--(Newsfile Corp. - January 25, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Revance Therapeutic...
Shareholder Action Notice: The Schall Law Firm Encourages Investors in Revance Therapeutics, Inc. with Losses of $100...
Los Angeles, California--(Newsfile Corp. - January 24, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Revance Therapeutic...
RVNC ALERT: Thornton Law Firm Reminds Revance Therapeutics Investors of Securities Class Action
Boston, Massachusetts--(Newsfile Corp. - January 24, 2022) - The Thornton Law Firm reminds investors that a class action lawsuit has been filed on behalf of investors of Revance Therapeutics, Inc. (NASD...
UPCOMING DEADLINE: Revance Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action...
San Diego, California--(Newsfile Corp. - January 24, 2022) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Revance Therapeutics, Inc. (NASDAQ: RVNC) securities between Nove...
Revance Therapeutics Inc. News: Berger Montague Investigates Securities Fraud Allegations Against Revance Therapeutic...
Philadelphia, Pennsylvania--(Newsfile Corp. - January 24, 2022) - Berger Montague is investigating securities fraud allegations on behalf of investors who purchased the securities of Revance Therapeutic...
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Agai...
Radnor, Pennsylvania--(Newsfile Corp. - January 23, 2022) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed agai...
Revance Therapeutics Class Action Reminder
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Revance Therapeutics To Contact Him Directly To Discuss Their OptionsNew York, New York--...
INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Securities Class Action Lawsuit Has Been Filed on Behalf...
NEW YORK--(BUSINESS WIRE)---- $RVNC--The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California o...
Thornton Law Firm Reminds Revance Therapeutics (RVNC) Investors of Securities Class Action
Boston, Massachusetts--(Newsfile Corp. - January 21, 2022) - The Thornton Law Firm reminds investors that a class action lawsuit has been filed on behalf of investors of Revance Therapeutics, Inc. (NASD...
RVNC LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Revance Therapeuti...
New York, New York--(Newsfile Corp. - January 21, 2022) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Revance Therapeu...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Revance Therapeutics, Inc. a Class Action Lawsuit an...
NEW YORK, Jan. 20, 2022 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Revance Therapeuti...
SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Reminds RVNC Investors of Securities Fraud Class Action Lawsuit...
RADNOR, Pa., Jan. 20, 2022 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Revance Therapeutics, Inc. (...
RVNC CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Announces to Revance Therapeutics, Inc. Investors of Dead...
Radnor, Pennsylvania--(Newsfile Corp. - January 18, 2022) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Revance The...
Lost Money in Revance Therapeutics, Inc.?
OAKLAND, Calif.--(BUSINESS WIRE)---- $RVNC #RVNC--Gibbs Law Group continues to investigate potential legal claims on behalf of Revance investors.
Revance Receives Clarity on Path to Resubmission of the BLA for DaxibotulinumtoxinA for Injection Following Type A Me...
NASHVILLE, Tenn.--(BUSINESS WIRE)--Revance Receives Clarity on Path to Resubmission of the BLA for DaxibotulinumtoxinA for Injection Following Type A Meeting with FDA
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Revance Therapeutics,...
LOS ANGELES, Jan. 18, 2022 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Re...